URGN
UroGen Pharma Ltd.stockNASDAQ
Market OpenNov 19, 2026 9:50:30 AM EST
30.58USD+2.652%(+0.79)61,538
Pre-marketNov 19, 2026 8:31:30 AM EST
31.11USD+4.431%(+1.32)
URGN Financials
In Q3 FY 2026 (ended ), UroGen Pharma Ltd. (URGN) reported revenue of $89M, net income of −$1.46M, operating cash flow of −$15.2M, and assets of $271.87M (filed ).
Loading financial statements…
